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Introduction
Breast cancer is world’s most common mali-
gnancy among women (1). It is known that the inci-
dence of breast cancer varies in different ethnic grou-
ps, higher figures having been reported in North
America with lower incidence rate from Lower East
and Middle East.
Primary Breast Lymphoma (PBL) is a rare neopla-
sm that doesn’t show inter-racial differences in inci-
dence. In addiction, its outcome remains unclear as
compared to other lymphomas. The PBL incidence is
0.04% to 0.53% of all primary malignant tumors of
the breast and 2.2% of extranodal lymphomas. Most
breast lymphomas are diffuse B-cell type. The pro-
gnosis in breast PBLs is related to the cell type and cli-
nical stage, as in lymphomas located elsewhere. Diffe-
rentiation of PBL from other breast tumors is difficult
preoperatively, especially by fine-needle aspiration
biopsy (FNAB) in which it can resemble breast carci-
noma. 
We report two cases that were diagnosed as mali-
gnant on FNAB and as breast lymphoma on microsco-
pic evaluation of the incisional biopsy specimens. So-
me Authors claim that PBL may not be rare but occa-
sionally misdiagnosed as anaplastic carcinoma (2, 3).
A high index of clinical suspicion and modern ima-
ging are the key for the correct diagnosis.
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Case reports
Case n. 1
A 75 years old woman presented with a mass in the upper la-
teral quadrant of the right breast in April 2003. The patient had
no past or family history.
On admission, blood chemistry, including serum levels of tu-
mor markers CEA and CA. 15-3, showed no abnormalities except
anemia (Hb 8,7 g/dl). An ill-defined, firm and large tumor, mea-
suring 6,8 x 7,3 cm, was recognized in the upper lateral quadrant
of the breast; the tumor was fixed to the chest wall. Neither nip-
ple-areola complex discharge nor ipsilateral axillary lymphoadeno-
pathy was detected. 
An ultrasonography of the right breast revealed an hypoechoic
and heterogeneous mass; results of a fine needle aspiration cyto-
logy (FNAC) of the mass revealed infiltrating carcinoma.
A right radical mastectomy was performed and the histology
of the mass revealed diffuse large B-cell lymphoma according to
REAL classification.
The patient received postoperatively six cycles of systemic che-
motherapy with CHOP regimen (iv Cyclophosfamide 750 mg/m2;
Doxorubicin 50 mg/m2; Vincristine 2 mg; and Prednisone 50 mg
orally twice daily). Each cycle was three weeks apart.
The patient showed remarkable tolerance to treatment and
presently is disease-free.
Case n. 2
A 49 years old woman came to our institution for a lump that
was 2 cm in diameter and located in the upper lateral quadrant of
the left breast. The patient had no past medical history or family
history.
On admission the lesion was well circumscribed and firm,
measuring 2,6 x 1,7 cm. Laboratory tests were normal. A mammo-
gram revealed a tumor shadow without microcalcifications or spi-
culations; FNAC was positive for class II cells.
Lumpectomy and sentinel node biopsy were carried out and
the tumor was diagnosed as malignat lymphoma (stage III E by
Ann Arbor staging), extranodal marginal zone B-cell lymphoma
(low grade B-cell lymphoma of MALT type) by REAL classifica-
tion.
This case was classified as a low-intermediate risk disease and
the patient underwent, after surgery, six cycles of CHOP regimen
(Cyclophosfamide 670 mg /m2 d.i.v day 1; ADM 45 mg/m2 d.i.v
day 1; and Prednisolone 50 mg orally days 1-5).
At the last control the patient was disease-free. 
Discussion
Breast cancer is the most common malignancy
among women in the world; hormonal, environmen-
tal and genetic factors have been shown to play an im-
portant role in the pathogenesis of breast malignan-
cies. The incidence of breast cancer varies in the diffe-
rent ethnic groups, and has the higher rate in North
America and Europe.
Breast limphoma, either a manifestation of pri-
mary extranodal disease or secondary involvement by
systemic disease, is a are malignancy. Primary breast
lymphoma (PBL) has a reported incidence ranging
from 0.12% to 0.53% of all breast malignancies. Se-
condary breast lymphoma had reported incidence of
0.07%, i.e. 17% of all malignancies metastatic to the
breast (4). Primary non-Hodgkin lymphoma of the
breast should fulfill following criteria: adequate
pathological evaluation, with both mammary and
lymphomatous infiltrate in closed association and ex-
clusion of either systemic lymphoma or previous ex-
tramammary lymphoma. Secondary lymphomas in-
volving the breast are infrequent as well, however they
represent the largest group of metastatic tumors to the
breast (5-6). The relative frequency of primary versus
secondary breast lymphomas is variably reported, the-
refore the prevalence of one type versus the other is
yet unclear.
It is important to determine whether ML of the
breast originated in the breast or elsewhere; some
Authors, infact, claim that PBL may be a not so rare
disease, mistaken at times for an anaplastic carcinoma,
as occurred indeed in one of our cases on the initial
biopsy (7-9). Secondary breast involvement should al-
so be considered when a breast mass appears or inflam-
matory changes occur in a patient previously diagno-
sed with lymphoma.
Metastasis to the breast is generally uncommon,
with a reported incidence of 1,3 – 6,5% of all breast
malignancies. Tumours commonly metastatizing to
the breast are lymphoma, leukaemia and malignant
melanoma.
Breast involement by lymphoma usually manifests
as a painless mass incidentally detected by self exami-
nation or clinical exams. The majority of cases are uni-
lateral and B–cell histological lineage as in our cases.
The mammogram often shows a homogeneus faint
tumor shadow without either microcalcification or
spiculation. Ultrasonography reveals a coarse internal
echo, a hypoechoic mass with irregular border and so-
metimes a lobulated mass representing a huge tumor
(10). It is common opinion that there are not typical
imaging characteristics able to distinguish it from
other breast masses or neoplasms. This mandates a
needle biopsy or an excision biopsy in the primary cli-
nical presentation.
In any case, it is very difficult to distinguish PBL
from breast cancer at early stage; often PBL is misdia-
gnosed because neither excisional biopsy with frozen
section nor FNAC is helpful in pathological differen-
tiation (11, 12).
Therapeutic management of PBL is controversial
and is not completely established as yet. Some authors
report that localized lesions within the breast have a
good prognosis by radical surgical interventation alo-
ne. However, many others report relapses 10 years af-
ter surgery without adjuvant therapy; on the other
hand if the lymphoma is diagnosed to be of systemic
origin, surgery plus chemotherapy is more effective
(13-15).
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Prognosis is variable and depends on histological
grade and clinical stage. Reported outcomes for PBL
in a series after 22,5 months of follow-up showed
complete remission in 67% of patients, partial respon-
se in 28% and progression of disease in 5%. Bilateral
diffuse disease has special predilection for pregnant
and lactating women (16, 17). 
As far as outcome is concerned, some authors state
that PBL has a grim outlook, despite various treatment
options, while others believe that prognosis is better
than that of a patient with disseminated lymphoma or
breast cancer, although survival has been deemed as in-
versely linked to tumour size (16, 17). Patients who re-
ceived chemotherapy and radiotherapy had a better
survival and a lower relapse rate.
Conclusion
In conclusion, despite the increasing prevalence of
breast cancer, PBL remains a rare event. A high index
of clinical suspicion, supported by modern imaging, is
the key in reaching the diagnosis. Currently, extensive
histopathology review is ongoing for tissue obtained in
the last decade to exclude the possibility of missed
PBL cases.
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